CA
GILD icon

Clearstead Advisors’s Gilead Sciences GILD Stock Holding History

Clearstead Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Sell
13,476
-3,306
-20% -$436K 0.02% 415
2026
Q1 		$2.34M Buy
16,782
+13,228
+372% +$1.85M 0.02% 331
2025
Q4 		$436K Sell
3,554
-68
-2% -$8.26K 0.01% 699
2025
Q3 		$402K Sell
3,622
-1,539
-30% -$175K 0.01% 696
2025
Q2 		$572K Buy
5,161
+2,175
+73% +$231K 0.01% 577
2025
Q1 		$335K Buy
2,986
+292
+11% +$30.1K 0.01% 678
2024
Q4 		$249K Sell
2,694
-428
-14% -$38.5K ﹤0.01% 787
2024
Q3 		$262K Sell
3,122
-85
-3% -$6.49K ﹤0.01% 767
2024
Q2 		$220K Buy
3,207
+5
+0.2% +$334 ﹤0.01% 794
2024
Q1 		$216K Sell
3,202
-57
-2% -$4.38K 0.01% 453
2023
Q4 		$264K Sell
3,259
-20
-0.6% -$1.56K 0.01% 422
2023
Q3 		$246K Buy
3,279
+501
+18% +$38.5K 0.02% 400
2023
Q2 		$214K Sell
2,778
-101
-4% -$8.05K 0.01% 421
2023
Q1 		$239K Buy
2,879
+476
+20% +$39.4K 0.02% 369
2022
Q4 		$206K Sell
2,403
-374
-13% -$29.6K 0.02% 376
2022
Q3 		$171K Buy
2,777
+487
+21% +$30.7K 0.02% 384
2022
Q2 		$142K Buy
2,290
+135
+6% +$8.36K 0.01% 431
2022
Q1 		$128K Buy
2,155
+1,085
+101% +$69.4K 0.01% 499
2021
Q4 		$78K Sell
1,070
-5,576
-84% -$384K 0.01% 580
2021
Q3 		$464K Buy
6,646
+196
+3% +$13.8K 0.03% 249
2021
Q2 		$444K Buy
6,450
+131
+2% +$8.75K 0.03% 242
2021
Q1 		$408K Sell
6,319
-406
-6% -$26.2K 0.03% 241
2020
Q4 		$392K Buy
6,725
+526
+8% +$31.7K 0.04% 228
2020
Q3 		$392K Sell
6,199
-312
-5% -$21.6K 0.04% 210
2020
Q2 		$501K Buy
6,511
+5,631
+640% +$432K 0.06% 174
2020
Q1 		$66K Buy
+880
New +$60.8K 0.01% 371
2017
Q3 		– Sell
-3,455
Closed -$245K – 251
2017
Q2 		$245K Sell
3,455
-965
-22% -$64.2K 0.04% 208
2017
Q1 		$300K Buy
4,420
+833
+23% +$58.6K 0.04% 178
2016
Q4 		$257K Buy
+3,587
New +$267K 0.04% 181

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clearstead Advisors's GILD Position: Q2 2026 in Review

Clearstead Advisors reduced its Gilead Sciences (GILD) stake by 20% in Q2 2026, selling an estimated $436K and leaving 13,476 shares worth $1.7M. The position accounts for 0.02% of the portfolio, ranked #415.

Clearstead Advisors first reported a position in GILD in Q4 2016 and has held it in 29 quarters since. The position peaked at $2.34M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Clearstead Advisors held 13,476 shares of Gilead Sciences worth $1.7M as of Q2 2026.
  • Clearstead Advisors sold 3,306 Gilead Sciences shares in Q2 2026, an estimated $436K.
  • Gilead Sciences made up 0.02% of Clearstead Advisors's portfolio in Q2 2026, its #415 holding.
  • Clearstead Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 29 quarters since.
  • Clearstead Advisors's Gilead Sciences position peaked at $2.34M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.